Immunomodulation for maxillofacial reconstructive surgery
10.1186/s40902-020-00249-4
- Author:
Seong-Gon KIM
1
Author Information
1. Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, Gangneung, Jukhyun-gil 25457, South Korea
- Publication Type:REVIEW
- From:Maxillofacial Plastic and Reconstructive Surgery
2020;42(1):5-
- CountryRepublic of Korea
-
Abstract:
Immunomodulation is a technique for the modulation of immune responses against graft material to improve surgical success rates. The main target cell for the immunomodulation is a macrophage because it is the reaction site of the graft and controls the healing process. Macrophages can be classified into M1 and M2 types. Most immunomodulation techniques focus on the rapid differentiation of M2-type macrophage. An M2 inducer, 4-hexylresorcinol, has been recently identified and is used for bone grafts and dental implant coatings.
